Chronic inflammatory demyelinating polyneuropathy (CIDP) diagnosis involves a neurological exam, nerve conduction studies, electromyography, cerebrospinal fluid analysis, nerve biopsy, and, in ...

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a long-term neurological disorder that targets your body’s nerves. Anyone can get CIDP, but it’s most common in older adults and ...

THE finding of areas of extensive perivascular demyelinization with a predilection for white matter in the brain of a patient who had had clinical tetanus provoked interest in the possible relation ...

Demyelination is damage to the myelin sheath around nerves. Learn what causes it and how doctors treat demyelinating diseases.

Patients with rheumatoid arthritis who take a tumor necrosis factor inhibitor do not appear to have a consistent and significant risk for developing a demyelinating disease.

What are the different types of these nerve disorders? WebMD covers transverse myelitis, neuromyelitis optica, ADEM, and more.

Northwestern Medicine scientists have discovered that mitochondria are not necessary for the proliferation of specialized immune cells in the central nervous system, but do help those cells respond to ...

Chronic inflammatory demyelinating polyneuropathy is an immune-mediated neuropathy that affects the peripheral motor and sensory nerves. The symptoms are of a slowly progressive numbness and tingling ...

The FDA has approved Vyvgart Hytrulo in a once-weekly, 30- to 90-second subcutaneous injection to treat adults with chronic inflammatory demyelinating polyneuropathy, according to the manufacturer ...

argenx announces FDA acceptance of supplemental Biologics License Application with Priority Review for Vyvgart Hytrulo in chronic inflammatory demyelinating polyneuropathy. News release. argenx SE.